Cersci Therapeutics has a total of 43 patents globally, out of which 6 have been granted. Of these 43 patents, more than 67% patents are active. United States of America is where Cersci Therapeutics has filed the maximum number of patents, followed by Mexico and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Cersci Therapeutics.
Cersci Therapeutics was founded in the year 2015. The Company is poised to deliver a new generation of non-opioid medicines to treat acute and chronic pain.
Do read about some of the most popular patents of Cersci Therapeutics which have been covered by us in this article and also you can find Cersci Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cersci Therapeutics patent portfolio.
How many patents does Cersci Therapeutics have?
Cersci Therapeutics has a total of 43 patents globally. These patents belong to 5 unique patent families. Out of 43 patents, 29 patents are active.
How Many Patents did Cersci Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Cersci Therapeutics Applications Filed | Cersci Therapeutics Patents Granted |
| 2022 | – | 3 |
| 2021 | 7 | – |
| 2020 | 13 | 2 |
| 2019 | 21 | – |
| 2018 | 1 | – |
| 2015 | – | 1 |
| 2011 | 1 | – |
How many Cersci Therapeutics patents are Alive/Dead?
How Many Patents did Cersci Therapeutics File in Different Countries?
Countries in which Cersci Therapeutics Filed Patents
| Country | Patents |
| United States Of America | 7 |
| Mexico | 3 |
| Australia | 3 |
| Canada | 3 |
| Brazil | 3 |
| Singapore | 3 |
| China | 3 |
| South Africa | 3 |
| Europe | 3 |
| Israel | 3 |
| New Zealand | 1 |
| Chile | 1 |
| Colombia | 1 |
| India | 1 |
Where are Research Centres of Cersci Therapeutics Patents Located?
The Research Centre for all the Cersci Therapeutics patents is the United States of America.
Best Cersci Therapeutics Patents
US9102636B2 is the most popular patent in the Cersci Therapeutics portfolio. It has received 14 citations so far from company like Actelion Pharmaceuticals Ltd.
List of Cersci Therapeutics Patents
| Cersci Therapeutics Patents | Title |
| US10844054B2 | Compounds For Pain Treatment, Compositions Comprising Same, And Methods Of Using Same |
| US10695287B2 | Ampk Agonist Topical Medication For The Treatment Of Certain Specific Medical Conditions, Methods Of Use Thereof And Wound Dressing Employing The Same |
| US9102636B2 | Analgesic Compounds, Compositions, And Uses Thereof |
| EP3966200A1 | Manufacturing Methods And Polymorphs Of A Thiazoline Anti-Hyperalgesic Agent |
| EP3917520A1 | Methods Of Treating Pain With A Thiazoline Anti-Hyperalgesic |
| EP3802524A1 | Compounds For Pain Treatment, Compositions Comprising Same, And Methods Of Using Same |
| CN112204025B | Compounds For Treating Pain, Compositions Comprising Same And Methods Of Using Same |
| CN113365626A | Methods Of Treating Pain With A Thiazoline Anti-Hyperalgesic |
| CA3136102A1 | Manufacturing Methods And Polymorphs Of A Thiazoline Anti-Hyperalgesic Agent |
| CA3126802A1 | Methods Of Treating Pain With A Thiazoline Anti-Hyperalgesic |
| CA3101738A1 | Compounds For Pain Treatment, Compositions Comprising Same, And Methods Of Using Same |
| AU2020275683A1 | Manufacturing Methods And Polymorphs Of A Thiazoline Anti-Hyperalgesic Agent |
| AU2019427298A1 | Methods Of Treating Pain With A Thiazoline Anti-Hyperalgesic |
| IL287776A | Manufacturing Methods And Polymorphs Of A Thiazoline Anti-Hyperalgesic Agent |
| IL284943A | Methods Of Treating Pain With A Thiazoline Anti-Hyperalgesic |
| IL278904A | Compounds For Pain Treatment, Compositions Comprising Same, And Methods Of Using Same |
| BR112020024261B8 | Compound Of Formula (Ia) And Pharmaceutical Composition |
| ZA202007320B | Compounds For Pain Treatment, Compositions Comprising Same, And Methods Of Using Same |
| CL202102855A1 | Manufacturing Methods And Polymorphs Of A Thiazoline Antihyperalgetic Agent |
| CO20210014873A2 | Manufacturing Methods And Polymorphs Of A Thiazoline Antihyperalgesic Agent |
| MX2021013524A | Manufacturing Methods And Polymorphs Of A Thiazoline Anti-Hyperalgesic Agent. |
| SG11202110561XA | Manufacturing Methods And Polymorphs Of A Thiazoline Anti-Hyperalgesic Agent |
| ZA202107091A | Manufacturing Methods And Polymorphs Of A Thiazoline Anti-Hyperalgesic Agent |
| MX2021009232A | Methods Of Treating Pain With A Thiazoline Anti-Hyperalgesic. |
| SG11202107875SA | Methods Of Treating Pain With A Thiazoline Anti-Hyperalgesic |
| ZA202104960A | Methods Of Treating Pain With A Thiazoline Anti-Hyperalgesic |
| MX2020012805A | Compounds For Pain Treatment, Compositions Comprising Same, And Methods Of Using Same. |
| SG11202011534YA | Compounds For Pain Treatment, Compositions Comprising Same, And Methods Of Using Same |
| NZ781034A | Manufacturing Methods And Polymorphs Of A Thiazoline Anti-Hyperalgesic Agent |
| US20200289474A1 | Methods Of Treating Pain With A Thiazoline Anti-Hyperalgesic |
| US20200246317A1 | Methods Of Treating Diabetic Neuropathy With A Thiazoline Anti-Hyperalgesic Agent |
| US20200246316A1 | Methods Of Treating Post-Surgical Pain With A Thiazoline Anti-Hyperalgesic Agent |
| US20200246318A1 | Methods Of Treating Pain With A Thiazoline Anti-Hyperalgesic |
| CN113874360A | Manufacturing Methods And Polymorphs Of A Thiazoline Anti-Hyperalgesic Agent |
| WO2020231496A1 | Manufacturing Methods And Polymorphs Of A Thiazoline Anti-Hyperalgesic Agent |
| WO2020159643A1 | Methods Of Treating Pain With A Thiazoline Anti-Hyperalgesic |
| WO2020159588A1 | Methods Of Treating Diabetic Neuropathy With A Thiazoline Anti-Hyperalgesic Agent |
| WO2020159565A1 | Methods Of Treating Post-Surgical Pain With A Thiazoline Anti-Hyperalgesic Agent |
| WO2019231739A1 | Compounds For Pain Treatment, Compositions Comprising Same, And Methods Of Using Same |
| AU2019279761A1 | Compounds For Pain Treatment, Compositions Comprising Same, And Methods Of Using Same |
| BR112021022478A2 | Compound Of Formula I, Pharmaceutical Composition, Crystalline Form Of Formula I Compound, Use Of Compound And Use Of Crystalline Form |
| BR112021015115A2 | Method Of Treatment Of Diabetic Neuropathy, Method Of Preparing A Compound And Kit |
| IN202017053263A | Compounds For Pain Treatment, Compositions Comprising Same, And Methods Of Using Same |
What are Cersci Therapeutics key innovation segments?
What Technologies are Covered by Cersci Therapeutics?
The chart below distributes patents filed by Cersci Therapeutics